Drugs / DLBS 1033 490 mg tablet 3 times daily
DLBS 1033 490 mg tablet 3 times daily
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04425590 | Apr → Aug 2020 | ischemic stroke | Duta Wacana Christian University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLBS 1033 490 mg tablet 3 times daily | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04425590 ↗ |
| Modality | Protein / enzyme biologic | “DLBS1033 is a bioactive protein fraction isolated from Lumbricus rubellus.” NCT04425590 ↗ |